Ophthotech Reports Conversion Of Option, Entered Exclusive Global License Deal With University Of Pennsylvania, University Of Florida Research Foundation For Rights To Develop, Commercialize Novel AAV Gen Therapy Product Candidates
Benzinga Newsdesk